Innoviva, Inc.

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 38% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Innoviva, Inc.'s trades of Entasis Therapeutics Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-07-13 2022-07-11
B Purchase
24,190 +33.9%
414.37
US$1,293,753 		24,190 +33.9% 414.37 US$1,293,753
2022-07-13 2022-07-08
B Purchase
54,165 -14.5%
290.11
US$3,346,825 		54,165 -14.5% 290.11 US$3,346,825
2022-04-01 2022-03-31
B Purchase
22,247 +40.1%
273.76
US$4,112,222 		22,247 +40.1% 273.76 US$4,112,222
2022-02-11 2022-02-09
B Purchase
3,614,792 +49.1%
5.00
US$18,073,960 		3,614,792 +49.1% 5.00 US$18,073,960
2021-11-01 2021-10-29
B Purchase
1,212,122 +19.7%
3.30
US$4,000,003 		1,212,122 +19.7% 3.30 US$4,000,003
2021-03-17 2021-03-17
B Purchase
4,285,935 +229.5%
3.25
US$13,929,289 		4,285,935 +229.5% 3.25 US$13,929,289
2021-01-28 2021-01-26
B Purchase
1,867,912 +inf%
3.25
US$6,070,714 		1,867,912 +inf% 3.25 US$6,070,714
2020-09-01 2020-09-01
B Purchase
4,672,897 +33.4%
2.68
US$12,499,999 		4,672,897 +33.4% 2.68 US$12,499,999
2020-06-12 2020-06-11
B Purchase
12,677,490 +958.6%
2.50
US$31,693,725 		12,677,490 +958.6% 2.50 US$31,693,725
2020-03-31 2020-03-27
B Purchase
7,717,661 +777.1%
2.87
US$22,149,687 		7,717,661 +777.1% 2.87 US$22,149,687